Caring Cross: Boro Dropulić's Big Idea That Might Change The World

The future of medicine may lie in how we overcome the challenges of accessibility and cost surrounding advanced therapies. Boro Dropulić, Executive Director and Co-Founder of Caring Cross, brings decades of experience in gene therapy to bear on a deeply personal mission: making potentially curative treatments like CAR-T cell therapy available to patients regardless of income or geography.

In this interview, Dropulić shares lessons from his career — from groundbreaking clinical trials to launching a nonprofit dedicated to affordability and equity in gene therapy. Along the way, he reflects on organizational culture, simple versus complex solutions, and the mindset required to lead innovation in a tightly regulated and fast-evolving field. With compelling real-world examples and a vision that challenges the prevailing norms of biotech commercialization, this conversation offers a powerful look at what it takes to reshape the future of healthcare — and who stands to benefit if we succeed.